Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
Conditions: Metastatic Prostate Cancer; Therapy, Directly Observed Interventions: Procedure: Cytoreductive prostatectomy or brachytherapy; Drug: ADT+second-generation antiandrogens ± chemotherapy Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brachytherapy | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Hospitals | Prostate Cancer | Prostatectomy | Research